We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Resection for Multiple Hepatocellular Carcinomas (HCC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01387061
Recruitment Status : Completed
First Posted : July 4, 2011
Last Update Posted : September 20, 2011
Information provided by (Responsible Party):

June 29, 2011
July 4, 2011
September 20, 2011
June 2001
June 2011   (Final data collection date for primary outcome measure)
Overall survival plus multivariate analysis [ Time Frame: 10 years ]
The primary endpoint of the study was the overall survival of patients resected for multiple HCC, and the univariate and multivariate analyses of prognostic factors for overall survival.
Same as current
Complete list of historical versions of study NCT01387061 on ClinicalTrials.gov Archive Site
Disease-free survival [ Time Frame: 10 years ]
The secondary endpoint was the disease-free survival.
Same as current
Not Provided
Not Provided
Resection for Multiple Hepatocellular Carcinomas (HCC)
Hepatic Resection for Multiple Hepatocellular Carcinoma on Cirrhosis
Surgical resection in patients with multiple hepatocellular carcinomas (HCC) remains controversial. The aim of this study was to investigate the outcome of a consecutive cohort of patients resected for multiple HCC, without macrovascular invasion, in order to identify clinically reliable parameters to select patients for surgery.
Not Provided
Not Provided
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Hepatocellular Carcinoma
  • Multiple Tumors
  • Cirrhosis
Procedure: hepatic resection
surgical resection of the liver for multiple HCC
Experimental: hepatic resection
Intervention: Procedure: hepatic resection
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
June 2011
June 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • patients with multiple HCC without macrovascular invasion on liver cirrhosis

Exclusion Criteria:

  • macrovascular invasion;
  • normal liver;
  • distant or lymphnodes metastasis
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Prof. Guido Torzilli, University of Milan
University of Milan
Not Provided
Study Chair: Guido Torzilli, MD, PhD University of Milan
University of Milan
September 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP